iSpecimen (ISPC) Share-based Compensation Growth (3y) (2023 - 2026)
iSpecimen (ISPC) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -1.05% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 32.51% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.86% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.55% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 5.74% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -7.98% |
| 10 | iSpecimen | 2.25 Mn | -2.16 Mn | 68,650.00 | -82.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -82.58% |
| Mar 31, 2026 | -82.31% |
| Dec 31, 2025 | -66.06% |
| Sep 30, 2025 | -92.73% |
| Jun 30, 2025 | -97.61% |
| Mar 31, 2025 | -81.54% |
| Dec 31, 2024 | -60.03% |
| Sep 30, 2024 | -47.73% |
| Jun 30, 2024 | 16.07% |
| Mar 31, 2024 | 9.71% |
| Dec 31, 2023 | 106.56% |
| Sep 30, 2023 | -18.14% |
| Jun 30, 2023 | 10.91% |